prothionamide
Prothionamide is a thioamide derivative with antibacterial properties. It increases cell wall permeability and decreases cell wall damage resistance by inhibition of mycolic acid synthesis, resulting in cell death. It is particularly used to treat M. tuberculosis and M. leprae infections.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
thioamide antibioticARO:3007156
- thioamide antibiotic
ARO:3007156
Chemical structure
| Molecular formula | C9H12N2S |
|---|---|
| Charge | 0 |
| Average mass | 180.276 Da |
| Monoisotopic mass | 180.07212 Da |
| Source | ChEBI |
| InChIKey | VRDIULHPQTYCLN-UHFFFAOYSA-N |
CCCc1cc(C(N)=S)ccn1
InChI=1S/C9H12N2S/c1-2-3-8-6-7(9(10)12)4-5-11-8/h4-6H,2-3H2,1H3,(H2,10,12)
Also called
- protionamide
Cross-references
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3004025 |
prothionamide | antibioticmech:aro-399b14c9b0 |
2026-08-30 |
Activity spectrum
| Organism | Activity | MIC | Disk diffusion | Assay | Strain | Sample/genome | Evidence |
|---|---|---|---|---|---|---|---|
| Mycobacterium tuberculosis complex | RESISTANT | — | — | CRyPTIC DST; CLIRES2020; liquid media; MGIT; MGIT960 | — |
1 source isolates 1 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | — | — | CRyPTIC DST; CLIRES2020; liquid media; MGIT; MGIT960 | — |
5 source isolates 5 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | — | — | CRyPTIC DST; CLIRES2020; not specified | — |
2 source isolates 2 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | — | — | CRyPTIC DST; CLIRES2020; solid media | — |
11 source isolates 11 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | — | — | CRyPTIC DST; CLIRES2020; solid media | — |
757 source isolates 757 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | — | — | CRyPTIC DST; CLIRES2023; liquid media; MGIT; MGIT960 | — |
1 source isolates 1 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | — | — | CRyPTIC DST; CLIRES2023; liquid media; MGIT; MGIT960 | — |
1 source isolates 1 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | — | — | CRyPTIC DST; CLIRES2023; not specified | — |
1 source isolates 1 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | — | — | CRyPTIC DST; PHE2019; liquid media; MGIT; MGIT960; critical concentration WHO mg/L | — |
45 source isolates 45 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | — | — | CRyPTIC DST; PHE2019; liquid media; MGIT; MGIT960; critical concentration WHO mg/L | — |
149 source isolates 149 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | — | — | CRyPTIC DST; SEQTREAT2020; liquid media; MGIT; MGIT960; critical concentration WHO mg/L | — |
246 source isolates 246 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | — | — | CRyPTIC DST; SEQTREAT2020; liquid media; MGIT; MGIT960; critical concentration WHO mg/L | — |
214 source isolates 214 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | — | — | — | CRyPTIC DST; SEQTREAT2020; liquid media; MGIT; MGIT960; critical concentration WHO mg/L | — |
296 source isolates 296 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | — | — | CRyPTIC DST; SEQTREAT2020; liquid media; MGIT; critical concentration WHO mg/L | — |
535 source isolates 535 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | — | — | CRyPTIC DST; SEQTREAT2020; liquid media; MGIT; critical concentration WHO mg/L | — |
888 source isolates 888 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | — | — | — | CRyPTIC DST; SEQTREAT2020; liquid media; MGIT; critical concentration WHO mg/L | — |
57 source isolates 57 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | RESISTANT | — | — | CRyPTIC DST; SEQTREAT2020; solid media; LJ; critical concentration WHO mg/L | — |
83 source isolates 83 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | SUSCEPTIBLE | — | — | CRyPTIC DST; SEQTREAT2020; solid media; LJ; critical concentration WHO mg/L | — |
80 source isolates 80 measurements |
EvidencePage data (JSON.gz) |
| Mycobacterium tuberculosis complex | — | — | — | CRyPTIC DST; SEQTREAT2020; solid media; LJ; critical concentration WHO mg/L | — |
15 source isolates 15 measurements |
EvidencePage data (JSON.gz) |
Resistance mechanisms
ANTIBIOTIC_TARGET_ALTERATION 4
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide | ARO:3005106 | — | ||
| Mycobacterium tuberculosis fabG1 with mutations conferring resistance to prothionamide | ARO:3007811 | — | ||
| Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide | ARO:3005102 | — | ||
| Mycobacterium tuberculosis mshA mutations conferring resistance to prothionamide | ARO:3005108 | — |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO, CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded; changed: activity_spectrum (CRYPTIC 3.4.0). Upstream retrieval date 2026-08-30, unchanged.
-
RESEEDED_FROM_SOURCES
Re-seeded; changed: activity_membership_collections (CRYPTIC 3.4.0). Upstream retrieval date 2026-08-30, unchanged.